A study of R&D, innovation, and business performance in the Canadian biotechnology industry

By Linda A. Hall, S. Bagchi‐Sen. 2002

293 citations recorded by the source corpus.

How researchers see this paper

The researchers whose trusted networks rank it highest, strongest advocate first. Every researcher gets a different order.

An econometric analysis of asymmetric volatility : Theory and application to patents (2007, background): “…2001); the effectiveness of patents versus secrets in innovation (Arundel, 2001); overseas innovations by Japanese firms (Belderbos, 2001); the Canadian biotechnology industry (Hall and Bagchi-Sen, 2002); and the analysis of Canon’s printers and Sanyo’s photovaltaics (Watanabe et al., 2001).”
Disentangling the effects of organizational capabilities, innovation and firm size on SME sales growth (2013, unknown): “Studies supporting the claim that new product introduction and sales growth are positively linked are often sector specific, and focus on such sectors as biotechnology (Hall and Bagchi-Sen 2002), seafood retailers (Bhaskaran 2006), industrial chemicals (Soni, Lilien and Wilson 1993), and”
Transformational leadership influence on organizational performance through organizational learning and innovation (2012, background): “…(Zahra et al., 2000; Zaltman et al., 1973), or between different aspects of organizational innovation (e.g., innovation design or speed, flexibility) and organizational performance (Calantoneet al., 2002;Capron, 1999;Danneels andKleinschmidt, 2001; Gopalakrishnan, 2000; Hall and Bagchi-Sen, 2000).”